Stay updated on Zephyrus II Pamrevlumab Clinical Trial

Sign up to get notified when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zephyrus II Pamrevlumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice announces an NIH terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T22:21:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:22:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:15:23.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The Researcher view now renders a 403 Forbidden error page, replacing the study details. This indicates an access restriction or server issue that prevents viewing the NCT04419558 record.
    Difference
    21%
    Check dated 2026-09-19T20:22:41.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision line updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata. There are no changes to study content or visible data.
    Difference
    0.1%
    Check dated 2026-08-29T20:58:21.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5 instead of v3.6.4, indicating a minor metadata update. This does not alter the study data or visible content.
    Difference
    0.1%
    Check dated 2026-08-08T11:06:20.000Z thumbnail image

Stay in the know with updates to Zephyrus II Pamrevlumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zephyrus II Pamrevlumab Clinical Trial page.